ASCO 2023 Highlights on erdafitinib in metastatic urothelial cancer with select FGFR alterations European Society for Medical Oncology (ESMO) 4:47 1 year ago 830 Скачать Далее
#ESMO21 Highlights on erdafitinib in adv. urothelial cancer with FGFRa alterations: The NORSE study European Society for Medical Oncology (ESMO) 2:47 2 years ago 1 280 Скачать Далее
Erdafitinib and enfortumab vedotin in pretreated FGFR2/3-mutant bladder cancer VJOncology 1:27 5 months ago 89 Скачать Далее
THOR: erdafitinib in metastatic urothelial cancer with FGFR alterations VJOncology 1:47 1 year ago 141 Скачать Далее
Phase III THOR study: erdafitinib vs. pembrolizumab in FGFR-altered advanced or metastatic UC VJOncology 3:37 9 months ago 315 Скачать Далее
The role of erdafitinib in treating patients with bladder cancer VJOncology 2:20 8 months ago 77 Скачать Далее
An update on erdafitinib for metastatic/uresectable FGFR alteration urothelial carcinoma VJOncology 2:31 5 years ago 452 Скачать Далее
Erdafitinib demonstrates efficacy in intermediate-risk NMIBC with FGFR alterations ecancer 5:14 1 year ago 69 Скачать Далее
BLC2001: erdafitinib for the treatment of metastatic urothelial carcinoma VJOncology 1:49 2 years ago 189 Скачать Далее
The future role of erdafitinib in advanced urothelial carcinoma VJOncology 1:47 1 year ago 59 Скачать Далее
Erdafitinib for bladder cancer: more to come following FDA approval VJOncology 1:28 4 years ago 402 Скачать Далее
RAGNAR: histology-agnostic trial of erdafitinib in FGFR3-mutant tumors VJOncology 1:34 1 year ago 80 Скачать Далее
What role will erdafitinib play in treating metastatic urothelial carcinoma? VJOncology 1:15 1 year ago 40 Скачать Далее
THOR: erdafitinib in advanced or metastatic urothelial cancer and FGFR alterations VJOncology 1:04 1 year ago 78 Скачать Далее
Erdafitinib +/- cetrelimab in mUC patients with FGFR alterations VJOncology 2:20 2 years ago 108 Скачать Далее
Expansion cohort results of RAGNAR: erdafitinib in CCA with FGFR alterations VJOncology 1:21 1 year ago 49 Скачать Далее
NORSE: erdafitinib + cetrelimab in mUC with FGFR alterations VJOncology 3:42 2 years ago 149 Скачать Далее